Literature DB >> 22975655

Patient-reported benefit from oculoplastic surgery.

H B Smith1, S B Jyothi, O A R Mahroo, P N Shams, M Sira, S Dey, T Adewoyin, V T F Cheung, C A Jones.   

Abstract

PURPOSE: It is vital that surgeons undertaking oculoplastic procedures are able to show that the surgery they perform is of benefit to their patients. Not only is this fundamental to patient-centred medicine but it is also important in demonstrating cost effectiveness. There are several ways in which benefit can be measured, including clinical scales, functional ability scales, and global quality-of-life scales. The Glasgow benefit inventory (GBI) is an example of a patient-reported, questionnaire-based, post-interventional quality-of-life scale that can be used to compare a range of different treatments for a variety of conditions.
METHODS: A cross-sectional study was undertaken using the GBI to score patient benefit from four commonly performed oculoplastic procedures. It was completed for 66 entropion repairs, 50 ptosis repairs, 41 ectropion repairs, and 41 external dacryocystorhinostomies (DCR). The GBI generates a scale from -100 (maximal detriment) through zero (no change) to +100 (maximal benefit).
RESULTS: The total GBI scores of patients undergoing surgery for entropion, ptosis, ectropion, and external DCR were: +25.25 (95% CI 20.00-30.50, P<0.001), +24.89 (95% CI 20.04-29.73, P<0.001), +17.68 (95% CI 9.46-25.91, P<0.001), and +32.25 (95% CI 21.47-43.03, P<0.001), respectively, demonstrating a statistically significant benefit from all procedures.
CONCLUSION: Patients derived significant quality-of-life benefits from the four most commonly performed oculoplastic procedures.

Entities:  

Mesh:

Year:  2012        PMID: 22975655      PMCID: PMC3496101          DOI: 10.1038/eye.2012.188

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Measuring quality of life: Is quality of life determined by expectations or experience?

Authors:  A J Carr; B Gibson; P G Robinson
Journal:  BMJ       Date:  2001-05-19

2.  The impact of functional endoscopic sinus surgery on health status.

Authors:  M Salhab; V Matai; M A Salam
Journal:  Rhinology       Date:  2004-06       Impact factor: 3.681

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Impact on quality of life of botulinum toxin treatments for essential blepharospasm.

Authors:  Kerr MacAndie; Ewan Kemp
Journal:  Orbit       Date:  2004-12

5.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

6.  Change in health status after rhinoplasty.

Authors:  Mark R Draper; Mahmoud A Salam; Sanjiv Kumar
Journal:  J Otolaryngol       Date:  2007-02

7.  Clinical research, comparison of the subjective visual function in patients with epiphora and patients with second-eye cataract.

Authors:  Namir Kafil-Hussain; Ramona Khooshebah
Journal:  Orbit       Date:  2005-03

8.  Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.

Authors:  N Bhattacharyya; D Tarsy
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-04

9.  Correlation of the vision-related functional impairment associated with blepharoptosis and the impact of blepharoptosis surgery.

Authors:  T J Federici; D R Meyer; L L Lininger
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

10.  The impact of endonasal dacryocystorhinostomy (DCR), on patient health status as assessed by the Glasgow benefit inventory.

Authors:  P M Spielmann; I Hathorn; F Ahsan; A J Cain; P S White
Journal:  Rhinology       Date:  2009-03       Impact factor: 3.681

View more
  7 in total

1.  Exploring correlations between change in visual acuity following routine cataract surgery and improvement in quality of life assessed with the Glasgow Benefit Inventory.

Authors:  Mohamed Katta; Priya Udani; B Sanjeev Heemraz; Chan Ning Lee; Christopher J Hammond; Omar A Mahroo
Journal:  Eye (Lond)       Date:  2018-05-18       Impact factor: 3.775

2.  Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.

Authors:  Z Sipkova; O Vonica; O Olurin; E E Obi; A R Pearson
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

3.  Long term patient-reported benefit from ptosis surgery.

Authors:  N Maycock; C MacGregor; D A Saunders; B Parkin
Journal:  Eye (Lond)       Date:  2015-04-17       Impact factor: 3.775

4.  Anterior approach white line advancement: technique and long-term outcomes in the correction of blepharoptosis.

Authors:  C B Schulz; R Nicholson; A Penwarden; B Parkin
Journal:  Eye (Lond)       Date:  2017-08-11       Impact factor: 3.775

5.  Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.

Authors:  Andrew G Lee; Shin-Hyo Lee; Minsu Jang; Sang Jae Lee; Hyun Jin Shin
Journal:  Toxins (Basel)       Date:  2021-01-21       Impact factor: 4.546

Review 6.  The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure.

Authors:  J Hendry; A Chin; I R C Swan; M A Akeroyd; G G Browning
Journal:  Clin Otolaryngol       Date:  2016-02-07       Impact factor: 2.597

7.  Patient reported psychosocial functioning following successful ptosis surgery.

Authors:  H S Richards; E Jenkinson; P White; R A Harrad
Journal:  Eye (Lond)       Date:  2021-07-29       Impact factor: 4.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.